ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Protagenic Therapeutics Inc

Protagenic Therapeutics Inc (PTIX)

0,555
0,0228
(4,28%)
Geschlossen 28 Dezember 10:00PM
0,5558
0,0008
(0,14%)
Nach Börsenschluss: 1:53AM

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

Current Price
0,5558
Gebot
0,51
Fragen
0,5558
Volumen
676.402
0,466518 Tagesbereich 0,56
0,44 52-Wochen-Bereich 1,87
Marktkapitalisierung
Handelsende
0,5322
Handelsbeginn
0,539
Letzte Trade
28
@
0.5558
Letzter Handelszeitpunkt
Finanzvolumen
US$ 345.507
VWAP
0,510802
Durchschnittliches Volumen (3 Mio.)
256.326
Ausgegebene Aktien
6.794.821
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-0,73
Gewinn pro Aktie (EPS)
-0,74
Erlöse
-
Nettogewinn
-5M

Über Protagenic Therapeutics Inc

Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression and neurodegenerative disorders by using peptide-based and brain activ... Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression and neurodegenerative disorders by using peptide-based and brain active therapeutics. The company's lead compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders. Mehr anzeigen

Sektor
Business Services, Nec
Branche
Books: Pubg, Pubg & Printing
Hauptsitz
Wilmington, Delaware, USA
Gegründet
2007
Protagenic Therapeutics Inc is listed in the Business Services sector of the NASDAQ with ticker PTIX. The last closing price for Protagenic Therapeutics was US$0,53. Over the last year, Protagenic Therapeutics shares have traded in a share price range of US$ 0,44 to US$ 1,87.

Protagenic Therapeutics currently has 6.794.821 shares in issue. The market capitalisation of Protagenic Therapeutics is US$3,62 million. Protagenic Therapeutics has a price to earnings ratio (PE ratio) of -0.73.

PTIX Neueste Nachrichten

Protagenic Therapeutics Announces Third Quarter 2021 Results and Business Update

NEW YORK, Nov. 16, 2021 (GLOBE NEWSWIRE) -- Protagenic Therapeutics, Inc. (Nasdaq: PTIX) a biopharmaceutical company focused on developing therapies to treat stress-related neurologic disorders...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.0882-13.69565217390.6440.79990.448241390.55339029CS
4-0.0602-9.772727272730.6160.79990.443352340.55795039CS
12-0.0752-11.91759112520.6311.090.442563260.65000909CS
26-0.3284-37.14091834430.88421.10990.442332550.75898198CS
52-0.2342-29.64556962030.791.870.441235020.787924CS
156-6.1642-91.72916666676.726.720.44634991.68486606CS
260-14.4042-96.284759358314.9619.560.4434411910.39960676CS

PTIX - Frequently Asked Questions (FAQ)

What is the current Protagenic Therapeutics share price?
The current share price of Protagenic Therapeutics is US$ 0,5558
How many Protagenic Therapeutics shares are in issue?
Protagenic Therapeutics has 6.794.821 shares in issue
What is the market cap of Protagenic Therapeutics?
The market capitalisation of Protagenic Therapeutics is USD 3,62M
What is the 1 year trading range for Protagenic Therapeutics share price?
Protagenic Therapeutics has traded in the range of US$ 0,44 to US$ 1,87 during the past year
What is the PE ratio of Protagenic Therapeutics?
The price to earnings ratio of Protagenic Therapeutics is -0,73
What is the reporting currency for Protagenic Therapeutics?
Protagenic Therapeutics reports financial results in USD
What is the latest annual profit for Protagenic Therapeutics?
The latest annual profit of Protagenic Therapeutics is USD -5M
What is the registered address of Protagenic Therapeutics?
The registered address for Protagenic Therapeutics is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Protagenic Therapeutics website address?
The website address for Protagenic Therapeutics is www.protagenic.com
Which industry sector does Protagenic Therapeutics operate in?
Protagenic Therapeutics operates in the BOOKS: PUBG, PUBG & PRINTING sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
INTZIntrusion Inc
US$ 2,167
(381,56%)
189,59M
AILEiLearningEngines Inc
US$ 0,5932
(267,31%)
563,26M
HUBCWHub Cyber Security Ltd
US$ 0,035
(250,00%)
2,79M
GTIGraphjet Technology
US$ 0,967551
(185,83%)
398,95M
LITMSnow Lake Resources Ltd
US$ 1,61
(82,95%)
131,98M
NEUPNeuphoria Therapeutics Inc
US$ 4,11
(-92,30%)
940,73k
VIRXViracta Therapeutics Inc
US$ 0,16
(-32,49%)
9,47M
PRFXPainReform Ltd
US$ 3,48
(-28,98%)
949,52k
AIREreAlpha Tech Corporation
US$ 2,56
(-28,49%)
8,42M
AVGRAvinger Inc
US$ 0,9721
(-24,05%)
2,16M
AILEiLearningEngines Inc
US$ 0,5932
(267,31%)
557,72M
GTIGraphjet Technology
US$ 0,967551
(185,83%)
398,75M
RGTIRigetti Computing Inc
US$ 17,08
(10,62%)
298,47M
XTIAXTI Aerospace Inc
US$ 0,03935
(-1,63%)
263,01M
QSIQuantum Si Inc
US$ 3,585
(66,74%)
250,36M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock